| Pharmaceutical active ingredients: |
| Chloroquine |
| Available forms, composition and doses of Bemasulph: |
| N / A |
| Bemasulph medical category: |
| Human:AntiamoebicsAntimalarialsDisease-modifying anti-rheumatic drugs (DMARDs)Eye anti-infectives and antiseptics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| P01BA01 - Chloroquine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Belsil DM | Dimethicone | Unidentified Pharmaceutical Company |
| Belvas | Lovastatin | Unidentified Pharmaceutical Company |
| Belzer Solution | Adenosine; Allopurinol; Glutathione; Hydroxyethyl Starch Modified; Insulin; Magnesium Sulfate; Potassium Lactobionate; Raffinose; Sodium Potassium Phosphate; Sulfamethoxazole; Trimethoprim | Unidentified Pharmaceutical Company |
| Bemaco | Chloroquine | Unidentified Pharmaceutical Company |
| Bemaphate | Chloroquine | Unidentified Pharmaceutical Company |
| Bemiparin | Heparin | Unidentified Pharmaceutical Company |
| Bemperil | Suloctidil | Unidentified Pharmaceutical Company |
| Benachlor | Diphenhydramine | Unidentified Pharmaceutical Company |
| Ben-A-Hist | Antazoline | Unidentified Pharmaceutical Company |
| Benaon | Medazepam | Unidentified Pharmaceutical Company |